
Further identifying proteins that help develop
and destroy cardiac muscle cells is a central
mission for the Cardiovascular Initiative. By
examining the roles specific molecules have
in normal and abnormal heart activity they
will be able to better understand the many
diseases that ultimately lead to heart failure.
Boston Biomedical’s Cardiovascular Initiative’s
discoveries are certain to produce better treatments
for heart disease heart attacks and
hypertension than are available today. |
| Lynne Coluccio, PhD | SENIOR SCIENTIST |
| Janice Dominov, PhD | SCIENTIST |
| Peter Erhardt, MD, PhD | SCIENTIST |
| Jim Fessenden, PhD | RESEARCH SCIENTIST |
| John Gergely, MD, PhD, DScM (HON) | SENIOR SCIENTIST |
| Zenon Grabarek, PhD | PRINCIPAL SCIENTIST |
| Phil Graceffa, PhD | SENIOR SCIENTIST |
| Noriaki Ikemoto, PhD | SENIOR SCIENTIST |
| Toshio Kitazawa, PhD | SENIOR SCIENTIST |
| Sam Lehrer, PhD | SENIOR SCIENTIST |
| Renne Lu, PhD | SENIOR SCIENTIST |
| Eddie Mabuchi, PhD | SENIOR RESEARCH ASSOCIATE |
| Jeff Miller, PhD | SENIOR SCIENTIST |
| Walter Stafford, PhD | SENIOR SCIENTIST |
| Shin Takayama, MD, PhD | PRINCIPAL SCIENTIST |
| Terry Tao, PhD | SENIOR SCIENTIST |
| Albert Wang, PhD | SENIOR SCIENTIST |
| Sarah Wilcox-Adelman, PhD | RESEARCH SCIENTIST |
| Hartmut Wohlrab, PhD | SENIOR SCIENTIST |